Inspire Medical Systems (INSP) stock plunged 8.28% in after-hours trading on Monday, following the company's disclosure that it received a civil investigative demand from the U.S. Department of Justice regarding an investigation into potential violations of federal law.
The medical device company, which focuses on obstructive sleep apnea treatments, said it received the civil investigative demand on January 17. However, the nature and scope of the investigation were not disclosed.
While the impact of the DOJ probe remains unclear, such investigations often carry significant legal risks and costs for companies. Investors reacted negatively to the news, sending Inspire Medical's shares sharply lower in the extended trading session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.